Who is sponsoring NCT01297894?

NCT01297894 is sponsored by Mahidol University.

What condition does NCT01297894 study?

NCT01297894 studies Drug Safety.

What drugs are being tested in NCT01297894?

Interventions: colistin, colistin plus fosfomycin.

What is the status of NCT01297894?

NCT01297894 is currently UNKNOWN.

Last reviewed 2011-12-24 · How we verify

Colistin Plus Fosfomycin in Multi-Drug Resistant Acinetobacter Baumannii

NCT01297894 Phase 3 UNKNOWN

In Siriraj Hospital, colistin alone for treatment of MDR A. baumannii contributed to mortality 45% Fosfomycin is an antimicrobial which has activity against gram-negative bacterial including MDR A. baumannii In this study, we compare the clinical and microbiologicalresponse of colistin alone versus colistin plus fosfomycin in treatment of A. baumannii infected patients

Details

Lead sponsor	Mahidol University
Phase	Phase 3
Status	UNKNOWN
Enrolment	92
Start date	2010-06
Completion	2012-05

Conditions

Drug Safety

Interventions

colistin
colistin plus fosfomycin

Primary outcomes

number of subjects with cure or improvement — up to 28days
cure improvement worse death

Countries

Thailand